Cutaneous canine mast cell tumour (CMCT) is a common cutaneous tumour in dog, with an incidence much higher than that found in human
. CMCT is classified in three subgroups, well and intermediately differentiated (G1 and G2), corresponding to a benign disease, and poorly differentiated (G3), corresponding to a malignant disease which metastasize to lymph nodes, liver, spleen and bone marrow with a short overall survival [28] . [29, 30] . In order to generate S, blood was allowed to coagulate for at least 30 min. at 37°C and then centrifuged at 1500 ϫ g ϫ 15 min. [29] . CTAD samples were centrifuged at 180 ϫ g ϫ 10 min. [30] . The supernatant was carefully removed from the centre portion of the liquid phase using a polyethylene Pasteur pipette to obtain a platelet-rich plasma. After removing the supernatant, the samples were again centrifuged at 1500 ϫ g ϫ 15 min. to obtain a P-PP. After subjecting the platelet-rich plasma to platelet count (Automated Haematology Analyser SE-9000 RET/SYSMEX Corporation, Kobe, Japan), it was treated with thrombin (80 ml/ml) and incubated for 30 min. at room temperature. After centrifugation at 1500 ϫ g ϫ 15 min., the aggregated platelet sediment was eliminated and the supernatant, P-APR, was obtained. All samples were stored at -80ЊC until VEGF detection [29] [30] [31] . (Fig. 2) . No significantly differences was found among the three subgroups in term of MCD ( Table 1) .
In this study, we have evaluated serum (S), platelet-poor plasma (P-PP), plasma-activated platelet rich (P-APR) and cytosol VEGF concentrations, microvascular density (MVD) and mast cell density (MCD) in a series of 86 CMCTs and we have correlated them with each other.

Material and methods
Blood samples
Blood samples were obtained from a series of 86 cases of CMCT. Venous blood was dispensed into a serum separator tube (Becton Dickinson Vacutainer Systems, Plymouth, UK) for S, into a sodium citrate, theophylline, adenosine, dipyridamole tubes for plasma (CTAD) (Becton Dickinson Hemogard Vacutainer Systems) for each case, respectively
VEGF ELISA detection
As concerns VEGF immunoreactivity, both MCs and microvessels were positive to VEGF in G3 CMCTs subgroup (Fig. 3) .
A (Fig. 4) . [5] .
Discussion
This is the first report describing the relationship between cytosol and circulating VEGF levels, MVD and MCD in regulating tumour angiogenesis and progression of CMCT spontaneous model. MCs' involvement in tumour angiogenesis has been demonstrated in several human solid and haematological malignancies [14-23]. Although MCs can secrete several pro-angiogenic molecules, including fibroblast growth factor-2 (FGF-2), tumour necrosis factor alpha (TNF-␣), interleukin-8 (IL-8), transforming growth factor beta (TGF-␤), tryptase and chymase,
Fig. 1 Haematoxylin-eosin staining of CMCTs in a low vascularized welldifferentiated (G1) tumour (A), low vascularized intermediately differentiated (G2) tumour (B) and high vascularized poorly differentiated (G3) tumour (C). Single arrows indicate blood vessels. Original magnification: A-C, x40. we have focused our attention on VEGF due to its main role in tumour angiogenesis, and to the possibility to inhibit angiogenesis by using a humanized anti-VEGF antibody, as it has been demonstrated in pre-clinical and clinical setting
Several reports in human tumours have suggested that serum VEGF could be unsuitable for sampling VEGF [29, 30, 37] . It has been demonstrated that VEGF is stored in the alpha granules and is released from platelets during clotting [38] [39] [40] 
Fig. 2 Highly vascularized poorly differentiated (G3) CMCT (A) and low vascularized well-differentiated (G1) CMCT (B) double stained with immunohistochemical method for vessels identification by using an antibody-anti FVIII-RA and with histochemical Undritz method for specific mast cells identification. In (A), arrows indicate two microvessels (red-brown colour) among several irregular pleomorphic blue degranulated (in inset in
Table 1 All angiogenetic indexes analysed means ± standard deviations as a function of tumour malignancy grade and statistical significance of their changes between G1 versus G2, G1 versus G3 and G2 versus G3 CMCT goups by Student's t-test
As concerns P-PP blood fraction, we found low VEGF levels and no statistically significant differences between P-PP and other angiogenic and grading parameters. The low VEGF levels in P-PP blood fraction suggests that VEGF from serum samples is derived from platelets during the coagulation process. Accordingly, VEGF levels in the P-PP could reflect the excess of circulating VEGF to the steady state with platelets levels without any biological clinical significance.
VEGF levels in P-APR serve to discriminate between cancer patients and healthy controls, suggesting that VEGF from P-APR may play a role in cancerogenesis [29, 30] . Human MCs can synthesize and secrete VEGF contained in their secretory granules, whereas platelets represent the main reservoir of circulating blood VEGF and they can endocytose and concentrate circulating plasma VEGF [41] [42] [43] [44] [45] [46] [47] [48] [49] .
In 
